Inhibition of Silencing and Accelerated Aging by Nicotinamide, a Putative Negative Regulator of Yeast Sir2 and Human SIRT1
Open accessThe DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
The Saccharomyces cerevisiae Sir2 protein is an NAD(+)-dependent histone deacetylase that plays a critical role in transcriptional silencing, genome stability, and longevity. A human homologue of Sir2, SIRT1, regulates the activity of the p53 tumor suppressor and inhibits apoptosis. The Sir2 deacetylation reaction generates two products: O-acetyl-ADP-ribose and nicotinamide, a precursor of nicotinic acid and a form of niacin/vitamin B(3). We show here that nicotinamide strongly inhibits yeast silencing, increases rDNA recombination, and shortens replicative life span to that of a sir2 mutant. Nicotinamide abolishes silencing and leads to an eventual delocalization of Sir2 even in G(1)-arrested cells, demonstrating that silent heterochromatin requires continual Sir2 activity. We show that physiological concentrations of nicotinamide noncompetitively inhibit both Sir2 and SIRT1 in vitro. The degree of inhibition by nicotinamide (IC(50) < 50 microm) is equal to or better than the most effective known synthetic inhibitors of this class of proteins. We propose a model whereby nicotinamide inhibits deacetylation by binding to a conserved pocket adjacent to NAD(+), thereby blocking NAD(+) hydrolysis. We discuss the possibility that nicotinamide is a physiologically relevant regulator of Sir2 enzymes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although NAM has been shown to be effective to increase NAD+ in tissues, it also exerts an inhibitory effect on sirtuin [88] and PARPs activity [89].”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [88]
In the citing paper
“Deacetylation of PGC-1α is required to sequester it in the nucleus and this cellular redistribution is prevented by nicotinamide, a potent SIRT1 inhibitor [64].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [64]
Citations
Cites
Genomic Expression Programs in the Response of Yeast Cells to Environmental Changes
Gasch, A. P., Spellman, P. T., Kao, C. M., Carmel-Harel, O., Eisen, M. B., Storz, G., Botstein, D., & Brown, P. O. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.12.4241 · Cited by 4,815
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S.-I., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,659
Kaeberlein, M., McVey, M., & Guarente, L. (1999) · Genes & Development · doi:10.1101/gad.13.19.2570 · Cited by 2,253
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
Histone deacetylases and cancer: causes and therapies
Marks, P. A., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T., & Kelly, W. K. (2001) · Nature reviews. Cancer · doi:10.1038/35106079 · Cited by 1,866
Lin, S.-J., Defossez, P.-A., & Guarente, L. (2000) · Science · doi:10.1126/science.289.5487.2126 · Cited by 1,775
Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans
Tissenbaum, H. A., & Guarente, L. (2001) · Nature · doi:10.1038/35065638 · Cited by 1,603
Extrachromosomal rDNA circles—a cause of aging in yeast
Sinclair, D. A., & Guarente, L. (1997) · Cell · doi:10.1016/s0092-8674(00)80493-6 · Cited by 1,500
Self-citationPosition effect at S. cerevisiae telomeres: Reversible repression of Pol II transcription
Gottschling, D. E., Aparicio, O. M., Billington, B. L., & Zakian, V. A. (1990) · Cell · doi:10.1016/0092-8674(90)90141-z · Cited by 1,345
Research works printed but not linked: 1
- Gasser, 1998, Novartis Found. Symp., 214, 114
Cited by
Items 601–700 of 1,000
Hu, B., Guo, Y., Chen, C., Li, Q., Niu, X., Guo, S., Zhang, A., Wang, Y., & Deng, Z. (2014) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0071-8 · Cited by 30
“deacetylation and base exchange (Sauve and Schramm 2003; Bitterman et al. 2002).”
BackgroundMittal, N., Muthuswami, R., & Madhubala, R. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005590 · Cited by 26
Engineering cord blood to improve engraftment after cord blood transplant
Mehta, R. S., Dave, H., Bollard, C. M., & Shpall, E. J. (2017) · Stem Cell Investigation · doi:10.21037/sci.2017.05.01 · Cited by 26
“Another method of blocking in vitro differentiation of EPCs is the use of a vitamin B3 analogue—NAM, which inhibits several key enzymes that require NAD+, including the sirtuin family of histone/protein deacetylases (such as SIRT1) that regulate several biological pathways involving cell adhesion, migration, prolifera…”
MethodThermodynamics—old laws in medicine and complex disease
Strohman, R. C. (2003) · Nature Biotechnology · doi:10.1038/nbt0503-477 · Cited by 31
Benjamin, C., & Crews, R. (2024) · Metabolites · doi:10.3390/metabo14060341 · Cited by 26
“Unlike NMN and NR, NAM can inhibit sirtuins, a class of proteins linked to NAD+ benefits [59,60].”
BackgroundNAD metabolism and heart failure: Mechanisms and therapeutic potentials
Walker, M. A., & Tian, R. (2024) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2024.07.008 · Cited by 27
Regulation of Cancer and Cancer-Related Genes via NAD +
Sharif, T., Martell, E., Dai, C., Ghassemi-Rad, M. S., Kennedy, B. E., Lee, P. W. K., & Gujar, S. A. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7478 · Cited by 27
“Interestingly, the NAM generated in deacetylase reactions by SIRTs acts as a negative feedback regulator of SIRT activity (17).”
Shi, H., Li, X., Xu, C., Zhang, D., Zhang, L., Xia, S., & Liu, W. (2020) · Aquaculture Nutrition · doi:10.1111/anu.13088 · Cited by 26
Progresses in both basic research and clinical trials of NAD+ in Parkinson’s disease
Maria Jose Perez, J., Baden, P., & Deleidi, M. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111499 · Cited by 27
Supplementing media with NAD+ precursors enhances the in vitro maturation of porcine oocytes
Pollard, C., Gibb, Z., Hawdon, A., Swegen, A., & Grupen, C. G. (2021) · Journal of Reproduction and Development · doi:10.1262/jrd.2021-080 · Cited by 25
Regulatory Effects of Statins on SIRT1 and Other Sirtuins in Cardiovascular Diseases
Khayatan, D., Razavi, S. M., Arab, Z. N., Khanahmadi, M., Momtaz, S., Butler, A. E., Montecucco, F., Markina, Y. V., Abdolghaffari, A. H., & Sahebkar, A. (2022) · Life · doi:10.3390/life12050760 · Cited by 28
“higher concentrations, can bind non-competitively and inhibit the activity of SIRTs [37,38].”
BackgroundSulfur Metabolism Actively Promotes Initiation of Cell Division in Yeast
Blank, H. M., Gajjar, S. R., Belyanin, A., & Polymenis, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008018 · Cited by 28
Alonso, V. L., & Serra, E. C. (2012) · BioMed Research International · doi:10.1155/2012/452934 · Cited by 26
“Sirtuins inhibitors were also described many years ago, for example, sirtinol [92–95] and nicotinamide, which is a product of the Sir2-catalyzed reaction [96].”
BackgroundAdaptive Potential of Epigenetic Switching During Adaptation to Fluctuating Environments
Stajic, D., Bank, C., & Gordo, I. (2022) · Genome Biology and Evolution · doi:10.1093/gbe/evac065 · Cited by 24
Rowlands, B. D., Lau, C. L., Ryall, J. G., Thomas, D. S., Klugmann, M., Beart, P. M., & Rae, C. D. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23570 · Cited by 26
“Nicotinamide, an inhibitor of SIRTs, has been shown to inhibit SIRT activity at physiological nicotinamide concentrations (<50 lM; Bitterman et al., 2002), suggesting that, under the conditions employed in the current study, SIRT1 might already have been extensively inhibited.”
BackgroundLee, S., Choi, S., Jung, I., Lee, K. W., & KANG, Y. Y. (2013) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2013.03.011 · Cited by 26
Loss of Cardioprotection With Ischemic Preconditioning in Aging Hearts: Role of Sir tuin 1?
Adam, T., Sharp, S., Opie, L. H., & Lecour, S. (2012) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248412458723 · Cited by 27
Cell cycle-dependent changes in H3K56ac in human cells
Stejskal, S., Štěpka, K., Tesařová, L., Stejskal, K., Matějková, M., Šimara, P., Zdráhal, Z., & Koutná, I. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1106760 · Cited by 25
Raj, C. J. T., Croft, T., Venkatakrishnan, P., Groth, B., Dhugga, G., Cater, T., & Lin, S.-J. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006987 · Cited by 24
“Although NAM can be deamidated into NA, it also inhibits the activity of the Sir2 family deacetylases (43, 44).”
BackgroundDantoft, W., Robertson, K. A., Watkins, W. J., Strobl, B., & Ghazal, P. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00355 · Cited by 24
“, 2013; Ekblad and Schüler, 2016) and another proposed approach in inhibiting SIRT6 activity is through administration of nicotineamide (NAM/Vitamin B3), which in addition to being a NAD precursor, also acts as an endogenous, non-competitive Sirtuin inhibitor (Bitterman et al., 2002).”
BackgroundFlores‐León, M., Pérez‐Domínguez, M., González‐Barrios, R., & Arias, C. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02810-8 · Cited by 25
Shan, T., Ren, Y., Wu, T., Liu, C. X., & Wang, Y. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22203 · Cited by 24
“In the current study, we found that NAM inhibited Sirt1 gene expression in cultured adipocytes confirming the well-established actions of NAM on Sirt1 [Bitterman et al., 2002; Jackson et al., 2003].”
BackgroundGetting a grip on O-acetyl-ADP-ribose
Hoff, K. G., & Wolberger, C. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb0705-560 · Cited by 25
Ito, T. K., Sato, T., Takanashi, Y., Tamannaa, Z., Kitamoto, T., Odagiri, K., & Setou, M. (2021) · Translational Medicine of Aging · doi:10.1016/j.tma.2021.09.001 · Cited by 25
Preyat, N., & Léo, O. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.08.110 · Cited by 24
Sakai, T., Matsumoto, Y., Ishikawa, M., Sugita, K., Hashimoto, Y., Wakai, N., Kitao, A., Morishita, E., Toyoshima, C., Hayashi, T., et al. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.11.027 · Cited by 24
Ha, C. W., Kim, K., Chang, Y. J., Kim, B., & Huh, W. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku570 · Cited by 24
“The enzymatic activity of Sir2 is regulated by an endogenous level of nicotinamide, a physiological inhibitor of Sir2 (9).”
BackgroundOrlandi, I., Pellegrino-Coppola, D., Strippoli, M., Ronzulli, R., & Vai, M. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.06.006 · Cited by 24
An acetylation rheostat for the control of muscle energy homeostasis
Menzies, K. J., & Auwerx, J. H. (2013) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0140 · Cited by 25
“As NAM can inhibit the different sirtuins (Bitterman 2002), the activity of the NADC salvage pathway becomes very important.”
BackgroundHistone Acetylation and Deacetylation
Fass, D. M., Kemp, M. M., Schroeder, F. A., Wagner, F. F., Wang, Q., & Holson, E. B. (2012) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.201100036 · Cited by 23
Sorum, A. W., Shrimp, J. H., Roberts, A. M., Montgomery, D. C., Tiwari, N. K., Lal‐Nag, M., Simeonov, A. M., Jadhav, A., & Meier, J. L. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00709 · Cited by 22
Nicotinamide as a Foundation for Treating Neurodegenerative Disease and Metabolic Disorders
Maiese, K. (2021) · Current Neurovascular Research · doi:10.2174/1567202617999210104220334 · Cited by 35
McClure, J. M., Gallo, C. M., Smith, D. L., Matecic, M., Hontz, R. D., Buck, S. W., Racette, F. G., & Smith, J. S. (2008) · Genetics · doi:10.1534/genetics.108.091090 · Cited by 23
“5–25 mm) to inhibit the various sirtuins in their experiments (Bitterman et al. 2002; Yeung et al. 2004; Tsuchiya et al. 2006).”
BackgroundInfluentialJeong, W.-Y., Kim, J.-B., Kim, H.-J., & Kim, C. (2017) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2017.1308243 · Cited by 22
Metastasis-associated protein 1 is an integral component of the circadian molecular machinery
Li, D., Pakala, S. B., Reddy, S. D. N., Peng, S., Balasenthil, S., Deng, C., Lee, C. C., Rea, M. A., & Kumar, R. (2013) · Nature Communications · doi:10.1038/ncomms3545 · Cited by 22
Carboxamide SIRT1 inhibitors block DBC1 binding via an acetylation-independent mechanism
Hubbard, B. P., Loh, C., Gomes, A. P., Li, J., Lu, Q., Doyle, T. L., Disch, J. S., Armour, S. M., Ellis, J. L., Vlasuk, G. P., et al. (2013) · Cell Cycle · doi:10.4161/cc.25268 · Cited by 22
Self-citationPurhonen, J., Rajendran, J., Tegelberg, S., Smolander, O., Pirinen, E., Kallijärvi, J., & Fellman, V. (2018) · The FASEB Journal · doi:10.1096/fj.201800090r · Cited by 26
“Nicotinamide is, however, a SIRT inhibitor (47) and was recently shown to repress hepatic nicotinamide salvage viaNAMPT and to suppress SIRT-1 activity (48).”
BackgroundNicotinamide, a vitamin B3 ameliorates depressive behaviors independent of SIRT1 activity in mice
Liu, Z., Li, C., Fan, X., Kuang, Y., Zhang, X., Chen, L., Song, J., Zhou, Y., Takahashi, E., He, G., et al. (2020) · Molecular Brain · doi:10.1186/s13041-020-00703-4 · Cited by 22
Weber, M., Locher, L., Huber, K., Rehage, J., Tienken, R., Meyer, U., Dänicke, S., Webb, L. A., Sauerwein, H., & Mielenz, M. (2015) · Journal of Dairy Science · doi:10.3168/jds.2015-10132 · Cited by 21
“During SIRT1-dependent deacetylation processes, NAD is converted to NAM, which inhibits SIRT1 activity (Bitterman et al., 2002).”
BackgroundZhao, Y., Dominska, M., Petrova, A., Bagshaw, H., Kokoska, R. J., & Petes, T. D. (2017) · Genetics · doi:10.1534/genetics.117.201285 · Cited by 22
Müller, M., Burmeister, A., Skowron, M. A., Stephan, A., Bremmer, F., Wakileh, G. A., Petzsch, P., Köhrer, K., Albers, P., & Nettersheim, D. (2022) · Clinical Epigenetics · doi:10.1186/s13148-021-01223-1 · Cited by 23
Tsang, F. A., & Lin, S.-J. (2015) · Frontiers in Biology · doi:10.1007/s11515-015-1367-x · Cited by 21
Wu, J., Li, Y., Chen, K., Jiang, H., Xu, M., & Liu, D. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.12.026 · Cited by 23
Feng, S., Guo, L., Wang, H., Yang, S., & Liu, H. (2023) · Communications Biology · doi:10.1038/s42003-023-04613-8 · Cited by 20
Potential Efficacy of Nutrient Supplements for Treatment or Prevention of COVID-19
Bogan-Brown, K. L., Nkrumah-Elie, Y. M., Ishtiaq, Y., Redpath, P., & Shao, A. E. (2021) · Journal of Dietary Supplements · doi:10.1080/19390211.2021.1881686 · Cited by 22
“NAM has also been used nutritionally and medicinally in humans, but there are questions surrounding the concentrations at which NAM can inhibit the important signaling enzymes that consume NADþ as a co-substrate (Bitterman et al. 2002).”
BackgroundSirtuins in Epigenetic Silencing and Control of Gene Expression in Model and Pathogenic Fungi
Zhao, G., & Rusché, L. N. (2022) · Annual Review of Microbiology · doi:10.1146/annurev-micro-041020-100926 · Cited by 23
Sirtuins as Regulators of the Yeast Metabolic Network
Ralser, M., Michel, S., & Breitenbach, M. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00032 · Cited by 23
“…ADP ribose moiety can be transferred to the protein substrates like histone H4, but the majority yields nicotinamide and a unique metabolite, 2′O-acetyl-ADPribose (OAADPR; Imai et al., 2000; Tanner et al., 2000; Moazed, 2001; Tanny and Moazed, 2001; Bitterman et al., 2002; Jackson and Denu, 2002).”
BackgroundOliaee, R. T., Sharifi, I., Bamorovat, M., Keyhani, A., Babaei, Z., Salarkia, E., Tavakoly, R., Khosravi, A., Mostafavi, M., Sharifi, F., et al. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106704 · Cited by 20
Lee, H. I., Jang, S., Kang, H. T., & Hwang, E. S. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.01.082 · Cited by 20
Hishida, T., Nozaki, Y., Nakachi, Y., Mizuno, Y., Iseki, H., Katano, M., Kamon, M., Hirasaki, M., Nishimoto, M., Okazaki, Y., et al. (2012) · Stem Cells · doi:10.1002/stem.1147 · Cited by 20
Overlapping Functions between SWR1 Deletion and H3K56 Acetylation in Candida albicans
Guan, Z., & Liu, H. (2015) · Eukaryotic Cell · doi:10.1128/ec.00002-15 · Cited by 22
“tively (22, 23) and increases H3K56ac levels, also promotes”
BackgroundExploring NNMT: from metabolic pathways to therapeutic targets
Park, J., Shin, E. J., Kim, T. H., Yang, J. H., Ki, S. H., Kang, K. W., & Kim, K. M. (2024) · Archives of Pharmacal Research · doi:10.1007/s12272-024-01519-9 · Cited by 21
“Both sirtuins and PARPs consume NAD + and release NAM, thereby suppressing its activity (Bitterman et al. 2002).”
Sirtuiny i ich rola w regulacji metabolizmu
Frydzińska, Z., Owczarek, A., & Winiarska, K. (2019) · Postępy Biochemii · doi:10.18388/pb.2019_254 · Cited by 21
Bucking, C., LeMoine, C. M. R., & Walsh, P. J. (2013) · Journal of Experimental Zoology Part A Ecological Genetics and Physiology · doi:10.1002/jez.1802 · Cited by 23
Shapiro, A. L. B., Ringham, B. M., Glueck, D. H., Norris, J. M., Barbour, L. A., Friedman, J. E., & Dabelea, D. (2017) · Maternal and Child Health Journal · doi:10.1007/s10995-016-2258-8 · Cited by 19
“Importantly, nicotinamide is a potent, non-competitive inhibitor of SIRT1 (Bitterman et al. 2002; Denu 2005) and may influence adipogenesis through a SIRT1 dependent pathway.”
BackgroundMuvva, C., Murugan, N. A., Choutipalli, V. S. K., & Subramanian, V. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00513 · Cited by 19
MicroRNA-34a induces apoptosis in PC12 cells by reducing B-cell lymphoma 2 and sirtuin-1 expression
Lin, Q., Mao, Y., Song, Y., & Huang, D. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4185 · Cited by 20
“As a highly-conserved NAD + induced deacetylase enzyme, SIRT1 was first identified in yeast, where, through regulation of downstream targets, such as p53, Foxo and Ku79, it is involved in reducing oxidative stress and apoptosis, and regulating gene silencing and cell cycle progression (30-32).”
Dynamic protein deacetylation is a limited carbon source for acetyl-CoA–dependent metabolism
Soaita, I., Megill, E., Kantner, D. S., Chatoff, A. G., Cheong, Y. J., Clarke, P., Arany, Z. P., Snyder, N. W., Wellen, K. E., & Trefely, S. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104772 · Cited by 20
Tcherniuk, S. O., Chesnokova, O. N., Oleinikov, I. V., & Oleinikov, A. V. (2017) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2017.06.004 · Cited by 18
“and bacterial sirtuin deacetylases Sir2Af2 and Sir2Tm [20], human SIRT1 and SIR2 of yeast [21] and P.”
BackgroundNucleotide Metabolism Behind Epigenetics
Suganuma, T., & Workman, J. L. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.731648 · Cited by 22
“The deacetylation activity of Sir2 and other sirtuins is inhibited by nicotinamide, which inhibits silencing at the telomeres, mating type loci, and rDNA (37, 38).”
BackgroundNicotinamide breaks effector CD8 T cell responses by targeting mTOR signaling
Agliano, F., Karginov, T. A., Ménoret, A., Provatas, A. A., & Vella, A. T. (2022) · iScience · doi:10.1016/j.isci.2022.103932 · Cited by 19
Locus dependence in epigenetic chromatin silencing
Mukhopadhyay, S., Nagaraj, V. H., & Sengupta, A. M. (2010) · Biosystems · doi:10.1016/j.biosystems.2010.07.012 · Cited by 18
“Experimentally, one could use an inhibitor of Sir2p, nicotinamide (NAM), to modulate its activity (Bitterman et al., 2002) (Fig.”
McConnell, M. J., Durand, L., Langley, E., Coste-Sarguet, L., Zelent, A., Chomienne, C., Kouzarides, T., Licht, J. D., & Guidez, F. (2015) · Epigenetics & Chromatin · doi:10.1186/s13072-015-0030-8 · Cited by 18
HIC 2, a new transcription activator of SIRT 1
Song, J., Lee, S., Kim, M. K., Jeon, B., Cho, S., Lee, S., Kim, K., & Hur, M. (2019) · FEBS Letters · doi:10.1002/1873-3468.13456 · Cited by 17
Sirtuin Evolution at the Dawn of Animal Life
Gold, D. A., & Sinclair, D. A. (2022) · Molecular Biology and Evolution · doi:10.1093/molbev/msac192 · Cited by 17
“NAM inhibits further sirtuin activity through negative feedback but can be converted back into NAD + through the enzymes nicotinamide phosphor-ibosyltransferase (NAMPT) and/or pyrimidine nucleotide carrier 1 (PNC1; Bitterman et al. 2002).”
Self-citationZadrąg‐Tęcza, R., Mołoń, M., Mamczur, J. A., & Biliński, T. (2013) · Acta Biochimica Polonica · doi:10.18388/abp.2013_1959 · Cited by 17
Reversible glutathionylation of Sir2 by monothiol glutaredoxins Grx3/4 regulates stress resistance
Vall‐llaura, N., Reverter‐Branchat, G., Vived, C., Weertman, N., Colman, M. J. R., & Cabiscol, E. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.04.008 · Cited by 17
Histone Deacetylases with Antagonistic Roles inSaccharomyces cerevisiaeHeterochromatin Formation
Thurtle-Schmidt, D. M., Dodson, A. E., & Rine, J. (2016) · Genetics · doi:10.1534/genetics.116.190835 · Cited by 20
“Restoration of silencing was dependent on Hst3, but independent of H3K56 Silencing is lost when yeast is grown in the presence of NAM, a competitive inhibitor of sirtuins (Landry et al. 2000; Bitterman et al. 2002).”
BackgroundLin, Y., Sam, J., & Evans, T. (2021) · iScience · doi:10.1016/j.isci.2021.103118 · Cited by 19
Structural and Kinetic Isotope Effect Studies of Nicotinamidase (Pnc1) from Saccharomyces cerevisiae
Smith, B. C., Anderson, M. A., Manthei, K. A., Keck, J. L., Cleland, W. W., & Denu, J. M. (2011) · Biochemistry · doi:10.1021/bi2015508 · Cited by 19
Titration and hysteresis in epigenetic chromatin silencing
Dayarian, A., & Sengupta, A. M. (2013) · Physical Biology · doi:10.1088/1478-3975/10/3/036005 · Cited by 18
Redox responses in yeast to acetate as the carbon source
Minard, K. I., & McAlister-Henn, L. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.12.014 · Cited by 18
Vestibular rehabilitation ameliorates chronic dizziness through the SIRT1 axis
Kao, C.-L., Tsai, K., Cheng, Y., Kuo, C., Lee, S., & Chan, R. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00027 · Cited by 18
“SIRT1 has been reported to play a central role in the regulation of chronic pathogenesis, such as diabetes, neurodegenerative, and chronic inflammatory diseases (Bitterman et al., 2002; Duan, 2013; Min et al., 2013).”
BackgroundScreening and profiling assays for HDACs and sirtuins
Howitz, K. T. (2015) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2015.10.008 · Cited by 17
“It should be noted that nicotinamide is a sirtuin inhibitor [7] and that O-acetyl-ADP-ribose has signaling functions [8–10].”
BackgroundBudzyński, M. A., Crul, T., Himanen, S. V., Tóth, N., Ötvös, F., Sistonen, L., & Vígh, L. (2017) · Cell Stress and Chaperones · doi:10.1007/s12192-017-0798-5 · Cited by 18
“We measured the deacetylation of a substrate in the presence of BGP-15 or the potent HDAC inhibitors TSA or nicotinamide (NAM) (Bitterman et al. 2002).”
InfluentialSIRT1 increases cardiomyocyte binucleation in the heart development
Shin, A. N., Han, L., Dasgupta, C., Huang, L., Yang, S., & Zhang, L. (2018) · Oncotarget · doi:10.18632/oncotarget.23847 · Cited by 17
“SIRT1 can also be activated through nicotinamide-depletion, whereas nicotinamide (NAM) itself is shown to inhibit SIRT1 activity [24].”
BackgroundMethodEnzymatic and Biological Characterization of Novel Sirtuin Modulators against Cancer
Carafa, V., Poziello, A., Torre, L. D., Giovannelli, P., Donato, M. D., Safadeh, E., Yu, Z., Baldi, A., Castoria, G., Tomaselli, D., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225654 · Cited by 17
“To date, the physiological SIRT inhibitor (SIRTi) nicotinamide (NAM) [15] and several other structurally unrelated SIRTi have been reported [16,17].”
BackgroundImpact of Short-Term Hypoxia on Sirtuins as Regulatory Elements in HUVECs
Pecher, S. J., Potthast, A. B., von Versen‐Höynck, F., & Das, A. M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082604 · Cited by 17
“In higher concentrations, NAM non-competitively binds the sirtuins and inhibits feedback [15].”
BackgroundIdentification of zinc finger transcription factor EGR2 as a novel acetylated protein
Noritsugu, K., Ito, A., Nakao, Y., & Yoshida, M. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.05.170 · Cited by 16
Campbell, M. T. D., Jones, D. S., Andrews, G. P., & Li, S. (2019) · Food & Nutrition Research · doi:10.29219/fnr.v63.3419 · Cited by 19
Ito, T. K., Sato, T., Hakamata, A., Onoda, Y., Sato, S., Yamazaki, F., Horikawa, M., Takahashi, Y., Kitamoto, T., Suzuki, M., et al. (2020) · Translational Medicine of Aging · doi:10.1016/j.tma.2020.04.002 · Cited by 19
Chubanava, S., & Treebak, J. T. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112109 · Cited by 17
Sir2-Related Protein 1 fromLeishmania amazonensisis a glycosylated NAD+-dependent deacetylase
Fessel, M. R., Lira, C. B. B., Giorgio, S., Ramos, C. H. I., & Cano, M. I. N. (2011) · Parasitology · doi:10.1017/s0031182011001077 · Cited by 19
“In addition, LaSir2RP1 deacetylase activity was inhibited at high NAD+ concentrations, probably due to the release of nicotinamide, a subproduct of the deacetylation reaction, and a known inhibitor of other Sir2-related proteins (Bitterman et al. 2002; Avalos et al. 2005).”
BackgroundThe Role of Lipin-1 in the Regulation of Fibrogenesis and TGF-β Signaling in Hepatic Stellate Cells
Jang, C. H., Kim, K. M., Yang, J. H., Cho, S. S., Kim, S. J., Shin, S. M., Cho, I. J., & Ki, S. H. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw109 · Cited by 17
Shao, D., Yao, C., Kim, M. H., Fry, J., Cohen, R. A., Costello, C. E., Matsui, R., Seta, F., McComb, M. E., & Bachschmid, M. M. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101150 · Cited by 18
Gaudino, F., Manfredonia, I., Managò, A., Audrito, V., Raffaelli, N., Vaisitti, T., & Deaglio, S. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7799 · Cited by 16
“This large family of NAD + -consuming enzymes includes adenosine diphosphate (ADP)-ribose transferases and poly (ADP-ribose) polymerases (PARPs), sirtuins (SIRTs), and cyclic ADP-ribose hydrolases (CD38/CD157) (27, 57).”
InfluentialTip60‐dependent acetylation of KDM2B promotes osteosarcoma carcinogenesis
Shi, X., & Fan, M. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14497 · Cited by 16
The role of sirtuins in dermal fibroblast function
Gilbert, M. M., Mathes, S. C., Mahajan, A. S., Rohan, C. A., Travers, J. B., & Thyagarajan‐Sahu, A. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1021908 · Cited by 19
Kim, M., Moon, S., Jeon, H. S., Kim, S., Koh, S., Chang, M., Kim, Y., & Choi, Y. K. (2022) · Cells · doi:10.3390/cells11050892 · Cited by 15
“To evaluate NAD+-dependent class I SIRTs, we used nicotinamide (NAM) as an inhibitor for class I SIRTs [21].”
MethodOKUDA, T., Furukawa, K., & Nakayama, K. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07215.x · Cited by 15
Mating-type locus control of killer toxins fromKluyveromyces lactisandPichia acaciae
Klassen, R., Jablonowski, D., Stark, M. J. R., Schaffrath, R., & Meinhardt, F. (2006) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2005.00006.x · Cited by 15
Rajan, K. E., Thangaleela, S., & Balasundaram, C. (2015) · Fish Physiology and Biochemistry · doi:10.1007/s10695-015-0038-9 · Cited by 15
“deacetylase (HDAC) (Bitterman et al. 2002).”
Mohibi, S., Srivastava, S., Bele, A., Mirza, S., Band, H., & Band, V. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00342-16 · Cited by 15
“Based on increased ADA3 acetylation specifically with a SIRT inhibitor, we further explored if one or more of the SIRTs are involved in deacetylation of ADA3.”
BackgroundMethodInfluentialAvrahami, E. M., Levi, S., Zajfman, E., Regev, C., Ben‐David, O., & Arbely, E. (2018) · ACS Synthetic Biology · doi:10.1021/acssynbio.8b00314 · Cited by 17
Dietary Restriction, Hormesis, and Small Molecule Mimetics
Sinclair, D. A., & Howitz, K. T. (2005) · Elsevier eBooks · doi:10.1016/b978-012088387-5/50006-6 · Cited by 18
Self-citationLocal Inflammatory Mediators Involved in Neuropathic Pain
García-Fernández, P., Reinhold, C., Üçeyler, N., & Sommer, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097814 · Cited by 15
Hajra, D., Rajmani, R. S., Chaudhary, A. D., Gupta, S. K., & Chakravortty, D. (2024) · eLife · doi:10.7554/elife.93125.4 · Cited by 14
Yamada, K., Miyazaki, T., Hara, N., & Tsuchiya, M. (2010) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.56.83 · Cited by 14
Hyun, D., & Lee, J. (2021) · Antioxidants · doi:10.3390/antiox11010007 · Cited by 17
“Interestingly, PM redox enzymes can be involved in extending lifespan in yeast and mammals by enhancing the NAD+/NADH ratio and activating SIRT1 [199,200].”
BackgroundThe use of Nicotinamide and Nicotinamide riboside as an adjunct therapy in the treatment of glaucoma
Silva, S. G. N. E., Occhiutto, M. L., & Costa, V. P. (2023) · European Journal of Ophthalmology · doi:10.1177/11206721231161101 · Cited by 14
“At high doses, NAM can also inhibit sirtuins, even in noncycling cells, which suggests that there may be deleterious consequences of long term NAM therapy in humans.(162) Another point is that a single 300 mg oral dose of NA and NAM has been shown to increase plasma homocysteine (HCY) levels.”
Background
Metadata
- Authors
- Bitterman, K. J., Anderson, R. M., Cohen, H. Y., Latorre-Esteves, M., & Sinclair, D. A.
- Affiliations
- Harvard University (US)
- Corresponding author
- Sinclair, David A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-11
- Volume
- 277
- Issue
- 47
- Pages
- 45099-45107
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2167990179
- Cited by
- 1,002
- References
- 66
- Citations by year
- 2026: 16 · 2025: 24 · 2024: 32 · 2023: 33 · 2022: 36 · 2021: 41 · 2020: 38 · 2019: 39 · 2018: 47 · 2017: 43 · 2016: 43 · 2015: 58 · 2014: 40 · 2013: 58 · 2012: 56
- FWCI
- 21.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6554 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG11972-01)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Keywords
- nicotinamide, Sir2, SIRT1, transcriptional silencing, heterochromatin, replicative lifespan, aging, NAD+ hydrolysis, enzyme inhibition, p53, apoptosis, histone deacetylation
- MeSH terms
- Aging, DNA, Ribosomal, Genes, Fungal, Histone Deacetylases, Humans, Life Expectancy, Luminescent Proteins, Models, Biological, Niacinamide, Recombinant Fusion Proteins, Recombination, Genetic, Saccharomyces cerevisiae, Molecular Structure, Telomere, Gene Silencing, Sirtuins, Silent Information Regulator Proteins, Saccharomyces cerevisiae, Green Fluorescent Proteins, Sirtuin 1, Sirtuin 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.